{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:34:32Z","timestamp":1793723672277,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012412","name":"Kansai Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.anl.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T07:22:52Z","timestamp":1672125772000},"page":"805-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Omalizumab is effective for a patient with pollen-food allergy syndrome who experienced intractable lip edema"],"prefix":"10.1016","volume":"50","author":[{"given":"Daiki","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3755-3074","authenticated-orcid":false,"given":"Yoshiki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Asako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anl.2022.12.001_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2222.1987.tb02317.x","article-title":"Oral allergy syndrome(OAS): symptoms of IgE-mediated hypersensitivity to foods","volume":"17","author":"Amlot","year":"1987","journal-title":"Clin Allergy"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/ACI.0000000000000533","article-title":"New findings, pathophysiology, and antigen analysis in pollen-food allergy syndrome","volume":"19","author":"Yagami","year":"2019","journal-title":"Curr Opin Allergy Clin Immnol"},{"issue":"2","key":"10.1016\/j.anl.2022.12.001_bib0003","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.alit.2017.02.001","article-title":"Japanese guidelines for food allergy 2017","volume":"66","author":"Ebisawa","year":"2017","journal-title":"Allergol Int"},{"issue":"11","key":"10.1016\/j.anl.2022.12.001_bib0004","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/pathogens10111412","article-title":"Plant Food Allergy Improvement after Grass Pollen Subligual Immunotherapy: A Case Series","volume":"10","author":"Furci","year":"2021","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.alit.2020.04.001","article-title":"Japanese guidelines for allergic rhinitis 2020","volume":"69","author":"Okubo","year":"2020","journal-title":"Allegol Int"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0006","first-page":"143","article-title":"Disappearance of severe oral allergy syndrome following omalizumab treatment","volume":"49","author":"Asero","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anl.2022.12.001_bib0007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000464326","article-title":"Comparison of the Performance of Skin Prick, ImmnoCAP, and ISAC Tests in the Diagnosis of Patients with Allergy","volume":"172","author":"Griffiths","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"10.1016\/j.anl.2022.12.001_bib0008","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1046\/j.1365-2222.1998.00399.x","article-title":"Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients","volume":"28","author":"Asero","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anl.2022.12.001_bib0009","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1398-9995.2003.00139.x","article-title":"How does the effect of birch pollen injection SIT on apple last?","volume":"58","author":"Asero","year":"2003","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0010","first-page":"211","article-title":"Evaluation of the effectiveness of subcutaneous immunotherapy using birch pollen extract for pollen-food allergy syndrome","volume":"67","author":"Tsumagari","year":"2018","journal-title":"Arerugi"},{"key":"10.1016\/j.anl.2022.12.001_bib0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mnfr.200400037","article-title":"Food allergy to apple and specific immunotherapy with birch pollen","volume":"48","author":"Hansen","year":"2004","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"10.1016\/j.anl.2022.12.001_bib0012","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaci.2006.11.010","article-title":"Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1","volume":"119","author":"Kinaciyan","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaci.2017.07.036","article-title":"Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy","volume":"141","author":"Kinaciyan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2022.12.001_bib0014","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2020.03.015","article-title":"IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy","volume":"146","author":"Sanches Acosta","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anl.2022.12.001_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000437325","article-title":"Japanese Cedar pollen-based subcutaneous immunotherapy decreases tomato fruit-specific basophil activation","volume":"167","author":"Inuo","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0016","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cea.13084","article-title":"The use of omalizumab in allergen immunotherapy","volume":"48","author":"Dantzer","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anl.2022.12.001_bib0017","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A randomized, double blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2022.12.001_bib0018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anl.2022.12.001_bib0019","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/all.15217","article-title":"Phase 2, randomized multi oral immunotherapy with omalizumab 'real life' study","volume":"77","author":"Sindher","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2022.12.001_bib0020","article-title":"Efficacy and safety of omalizumab for the treatment of severe or poorly controlled allergic diseases in children: A systematic review and meta-analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anl.2022.12.001_bib0021","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/JAA.S310888","article-title":"Omalizumab effectiveness in severe allergic asthma with multiple allergic comorbidities: A post-hoc analysis of the STELLAIR Study","volume":"14","author":"Just","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"3","key":"10.1016\/j.anl.2022.12.001_bib0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mai.2002.126380","article-title":"IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance","volume":"110","author":"Wensing","year":"2002","journal-title":"J Allergy Clin Immunol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:39:52Z","timestamp":1759952392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814622002292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0385814622002292"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2022.12.001","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab is effective for a patient with pollen-food allergy syndrome who experienced intractable lip edema","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}